tm logo
EXONDYS 51 (ETEPLIRSEN)
Live/Registered
REGISTERED

on 18 Apr 2023

Last Applicant/ Owned by

215 First Street

Cambridge

MA

02142

Serial Number

90857980 filed on 30th Jul 2021

Registration Number

7032061 registered on 18th Apr 2023

in the Principal Register

Correspondent Address

Maury M. Tepper, III

TEPPER & EYSTER, PLLC

3724 BENSON DRIVE

RALEIGH, NC 27609

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"51" AND "ETEPLIRSEN"

EXONDYS 51 (ETEPLIRSEN)

EXONDYS FIFTY ONE (ETEPLIRSEN); EXONDYS FIVE ONE (ETEPLIRSEN) Pharmaceutical preparations featuring antisense oligonucleotides for the treatment of neuromuscular diseases and disorders "51" AND "ETEPLIRSEN" The mark consists of a hexagon, encircled by a sash, followed by the text and numeral "EXONDYS 51" above the text "(eteplirsen)".

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations featuring antisense oligonucleotides for the treatment of neuromuscular diseases and disorders


First Use Date in General

19th Feb 2020

First Use Date in Commerce

19th Feb 2020

Mark Details


Serial Number

No 90857980

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.15.21 -

Polygons that are completely or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

Description of Design Search

The mark consists of a hexagon, encircled by a sash, followed by the text and numeral "EXONDYS 51" above the text "(eteplirsen)".

Legal History


Show more

Status DateAction Taken
18th Apr 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
18th Apr 2023REGISTERED-PRINCIPAL REGISTER
14th Mar 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12th Mar 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21st Feb 2023ASSIGNED TO LIE
21st Feb 2023TEAS/EMAIL CORRESPONDENCE ENTERED
21st Feb 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
15th Dec 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
12th Dec 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
12th Dec 2022NON-FINAL ACTION E-MAILED